Wall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here's What You Should Know

Amicus Therapeutics (FOLD) closed the last trading session at $11.47, gaining 8.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 17.33 indicates a 51.1% upside potential.The average comprises 12 short-term price targets ranging from a low of $13 to a high of$ 20, with a standard deviation of $2.39. While the lowest estimate indicates an increase of 13.3% from the current price l ...